IntercontinentalExchange (NYSE: ICE) , an operator of regulated global derivatives exchanges and over-the-counter (OTC) markets, will announce third quarter 2008 financial results on Thursday, October 30, 2008. An earnings press release will be issued prior to the earnings conference call, which will begin at 8:30 a.m. ET.
A live audio webcast of the earnings call will be available on the company's website at www.theice.com under About ICE/Investors & Media. Participants may also listen via telephone by dialing (877) 795-3646 if calling from the United States, or (719) 325-4774 if dialing from outside of the United States. For participants on the telephone, please place your call ten minutes prior to the start of the call.
The webcast will be archived on the company's website for replay. A telephone replay of the earnings call will also be available at (888) 203-1112 for callers within the United States and at (719) 457-0820 for callers outside of the United States. The passcode for the replay is 5433981.
Showing posts with label American Stock Exchange. Show all posts
Showing posts with label American Stock Exchange. Show all posts
Tuesday, 9 September 2008
Tuesday, 2 September 2008
BGI Moves ETFs Exchanges
Barclays Global Investors (BGI), one of the world's largest institutional asset managers and Exchange Traded Funds (ETF) managers, today announced the transfer of the iShares Nasdaq Biotechnology Index Fund (ticker: IBB) from the American Stock Exchange to The NASDAQ Stock Market and the move of the iShares S&P 100 Index Fund (ticker: OEF) from the Chicago Board Options Exchange to the NYSE Arca listing and trading platform on September 23, 2008. Current shareholders are not required to take any actions as a result of these changes.
"The natural listing location of the iShares Nasdaq Biotechnology Index Fund is The NASDAQ and the transfer of the iShares S&P 100 Index Fund to the NYSE Arca is logical as well since it is joining the other iShares S&P Funds," said Michael Latham, CEO of U.S. iShares at Barclays Global Investors. "We appreciate The NASDAQ and the NYSE Arca's support of the ETF marketplace."
The iShares Funds are index funds that are bought and sold like common stocks on securities exchanges. The iShares Funds are attractive to many individual and institutional investors and financial intermediaries because of their relative low cost, tax efficiency and trading flexibility. Investors can purchase and sell shares through any brokerage firm, financial advisor, or online broker, and hold the funds in any type of brokerage account.
"The natural listing location of the iShares Nasdaq Biotechnology Index Fund is The NASDAQ and the transfer of the iShares S&P 100 Index Fund to the NYSE Arca is logical as well since it is joining the other iShares S&P Funds," said Michael Latham, CEO of U.S. iShares at Barclays Global Investors. "We appreciate The NASDAQ and the NYSE Arca's support of the ETF marketplace."
The iShares Funds are index funds that are bought and sold like common stocks on securities exchanges. The iShares Funds are attractive to many individual and institutional investors and financial intermediaries because of their relative low cost, tax efficiency and trading flexibility. Investors can purchase and sell shares through any brokerage firm, financial advisor, or online broker, and hold the funds in any type of brokerage account.
Subscribe to:
Posts (Atom)